The start of the New Year is weight-loss resolution time, the appropriate week for the Federal Trade Commission to fine marketers of four over-the-counter diet pills: Trimspa, Cortislim, One-A-Day and Xenadrine. They will pay $25m for deceptive advertising. ABC's Lisa Stark (subscription required), who yesterday covered the new so-called calorie-burning soft drink Enviga, aired clips from a couple of the offending ads and reported that Xenadrine had conducted research and found that its product was actually worse than a placebo.
CBS' Sandra Hughes told us the fines were levied for "unsubstantiated claims about everything from reducing the risk of cancer to rapid weight loss." Because none of the products was ordered pulled from the shelves, Hughes cited FTC critics: "Little more than a slap on the wrist."
You must be logged in to this website to leave a comment. Please click here to log in so you can participate in the discussion.